Macrophages in Nonalcoholic Fatty Liver Disease: A Role Model of Pathogenic Immunometabolism

Semin Liver Dis. 2017 Aug;37(3):189-197. doi: 10.1055/s-0037-1604480. Epub 2017 Aug 28.

Authors

Oliver Krenkel¹, Frank Tacke¹

Affiliation

¹ Department of Medicine III, University Hospital Aachen, Aachen, Germany.

PMID: 28847030
DOI: 10.1055/s-0037-1604480

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
Anti-Inflammatory Agents / therapeutic use
Cytokines / immunology
Cytokines / metabolism
Energy Metabolism
Gastrointestinal Microbiome / immunology
Humans
Inflammation Mediators / immunology
Inflammation Mediators / metabolism
Kupffer Cells / immunology
Kupffer Cells / metabolism
Liver / drug effects
Liver / immunology*
Liver / metabolism
Liver / pathology
Liver Cirrhosis / drug therapy
Liver Cirrhosis / immunology*
Liver Cirrhosis / metabolism
Liver Cirrhosis / pathology
Macrophages / drug effects
Macrophages / immunology*
Macrophages / metabolism
Macrophages / pathology
Non-alcoholic Fatty Liver Disease / drug therapy
Non-alcoholic Fatty Liver Disease / immunology*
Non-alcoholic Fatty Liver Disease / metabolism
Non-alcoholic Fatty Liver Disease / pathology
Phenotype
Signal Transduction

Substances

Anti-Inflammatory Agents
Cytokines
Inflammation Mediators